Home » All » Stock Forecast » NeuroSense Therapeutics Ltd. Ordinary Shares Forecast

NeuroSense Therapeutics Ltd. Ordinary Shares Forecasts for Tomorrow, Week, Month and 5 Years

Updated: April 22 · 2026 at 07:03 UTC

From

▼ -2.82%Market Cap $24.39M · Technical analysis Bearish · Focus area Price + volatility

Forecast Summary

Timeframe	Predicted Price	Past	Historical	Insight
Tomorrow	$0.6979 ▲ +1.15%	Yesterday	$0.6867 ▼ -0.48%	Tomorrow's NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) setup is anchored to $0.6900 and targets $0.6979 (+1.15%). The near-term read is upside; watch $0.7107 / $0.6693 because daily realized volatility is about 5.93%.
Tomorrow's NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) setup is anchored to $0.6900 and targets $0.6979 (+1.15%). The near-term read is upside; watch $0.7107 / $0.6693 because daily realized volatility is about 5.93%.
Week	$0.7147 ▲ +3.58%	Last Week	$0.6796 ▼ -1.50%	The 7-day NeuroSense Therapeutics Ltd. Ordinary Shares model moves from $0.6796 to $0.7147 (+3.58%). It gives upside momentum context for this stock, so breaks around $0.7107 / $0.6693 matter more than a single tick.
The 7-day NeuroSense Therapeutics Ltd. Ordinary Shares model moves from $0.6796 to $0.7147 (+3.58%). It gives upside momentum context for this stock, so breaks around $0.7107 / $0.6693 matter more than a single tick.
Month	$0.7425 ▲ +7.61%	Last Month	$0.6679 ▼ -3.20%	The 1-month NeuroSense Therapeutics Ltd. Ordinary Shares target is $0.7425 (+7.61%), compared with the live reference near $0.6900. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
The 1-month NeuroSense Therapeutics Ltd. Ordinary Shares target is $0.7425 (+7.61%), compared with the live reference near $0.6900. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.
Year	$0.7843 ▲ +13.67%	Last Year	$0.6504 ▼ -5.74%	The 1-year NeuroSense Therapeutics Ltd. Ordinary Shares scenario points to $0.7843 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
The 1-year NeuroSense Therapeutics Ltd. Ordinary Shares scenario points to $0.7843 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.
5 Years	$0.8822 ▲ +27.86%	5 Years Ago	$0.6093 ▼ -11.70%	The 5-year NeuroSense Therapeutics Ltd. Ordinary Shares view is $0.8822 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.
The 5-year NeuroSense Therapeutics Ltd. Ordinary Shares view is $0.8822 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Tomorrow$0.6979▲ +1.15%

Yesterday$0.6867▼ -0.48%

Tomorrow's NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) setup is anchored to $0.6900 and targets $0.6979 (+1.15%). The near-term read is upside; watch $0.7107 / $0.6693 because daily realized volatility is about 5.93%.

Week$0.7147▲ +3.58%

Last Week$0.6796▼ -1.50%

The 7-day NeuroSense Therapeutics Ltd. Ordinary Shares model moves from $0.6796 to $0.7147 (+3.58%). It gives upside momentum context for this stock, so breaks around $0.7107 / $0.6693 matter more than a single tick.

Month$0.7425▲ +7.61%

Last Month$0.6679▼ -3.20%

The 1-month NeuroSense Therapeutics Ltd. Ordinary Shares target is $0.7425 (+7.61%), compared with the live reference near $0.6900. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk.

Year$0.7843▲ +13.67%

Last Year$0.6504▼ -5.74%

The 1-year NeuroSense Therapeutics Ltd. Ordinary Shares scenario points to $0.7843 (+13.67%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates.

5 Years$0.8822▲ +27.86%

5 Years Ago$0.6093▼ -11.70%

The 5-year NeuroSense Therapeutics Ltd. Ordinary Shares view is $0.8822 (+27.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path.

Risk notice:This forecast is informational only, not financial advice; accuracy depends on volatility, liquidity, macro events, and other external factors.

Price Chart

HistoricalForecastBullishBearish

Technical Analysis

Neutral

Bullish

Neutral

Bearish

Key Indicators

Indicator	Value	Signal
Price	$0.6900	Mid
Daily Change	-2.82%	Below
Volatility Cap	20.0%	Mid
Confidence	63%	Above
Data Source	nasdaq-screener	Mid

Historical Data

Current$0.6900

Daily Change-2.82%

Market Cap$24.39M

Sourcenasdaq-screener

Current	$0.6900	Daily Change	-2.82%
Market Cap	$24.39M	Source	nasdaq-screener

Support & Resistance Levels

$0.6693Support 1

$0.6900Current

$0.7107Resistance 1

Support and resistance are estimated from the trusted current price until deeper historical data is available.

Price Milestones

Key levels & historical context

Current$0.6900Live reference price

Used as the anchor for generated forecast calculations.

Next Month$0.7425Model projection+7.61%

Directional scenario based on capped drift.

Forecast Accuracy

How our model has performed

63%

Directional

Generated market-data forecast

This page uses live catalog market data and conservative volatility caps. It is informational, not financial advice.

📊

Our algorithm is re-calibrated weekly using the latest price action, volatility regime, and indicator signals. Accuracy varies by timeframe — short-term momentum is more reliable than long-term projections.

Short term

63%

Direction confidence

Long term

Lower

Forecast uncertainty rises with horizon

Investment Scenarios

If you invest $1,000 in NRSN today

Bullish Scenario

$0.7245

+5.00% from current

Target Price$0.7245

ScenarioUpside momentum

Probability55%

Base Scenario

$0.7425

+7.61%

Target Price$0.7425

ScenarioCapped drift

Probability63%

Bearish Scenario

$0.6555

-5.00% from current

Target Price$0.6555

ScenarioVolatility drawdown

Probability37%

Basis: Scenario model combines current spot price, recent market direction, and conservative asset-class volatility caps.

Forecast Factors

Market Structure

Price structure reflects the latest momentum regime and support/resistance interaction.

Momentum Bullish · 66/100

24H drift+1.15%

7D drift+3.58%

30D drift+7.61%

Technical Signals

Signals combine RSI, MACD, and moving average stacks to estimate short-term direction.

Mixed — Watching · 50/100

RSIn/a

MACDn/a

MA stackn/a

Macro Context

Rates, dollar strength, and cross-asset risk appetite influence medium-term paths.

Risk-On Tentative · 64/100

1M outlook+7.61%

1Y outlook+13.67%

5Y outlook+27.86%

Frequently Asked Questions

Q What is the NeuroSense Therapeutics Ltd. Ordinary Shares (NRSN) forecast for tomorrow?

Using the latest BeCoin market snapshot (April 22 · 2026 at 07:03 UTC), NeuroSense Therapeutics Ltd. Ordinary Shares is projected near $0.6979 versus the current reference around $0.6900. That implies a modeled move of +1.15% over the next day, with realized prices still sensitive to intraday volatility.

Q What does the 7-day stock outlook suggest for NRSN?

The weekly NeuroSense Therapeutics Ltd. Ordinary Shares model points to $0.7147, which maps to an expected drift of +3.58% from current conditions. This horizon reacts quickly to momentum shifts, so support/resistance breaks can change the path faster than long-term targets.

Q How should I read the NeuroSense Therapeutics Ltd. Ordinary Shares 1-month and 1-year targets?

The NeuroSense Therapeutics Ltd. Ordinary Shares 1-month target is $0.7425 (+7.61%), while the 1-year target is $0.7843 (+13.67%). The monthly view tracks prevailing trend pressure, and the yearly view reflects broader cycle assumptions shaped by price momentum, liquidity, and company-specific risk.

Q Why does the NeuroSense Therapeutics Ltd. Ordinary Shares 5-year scenario differ from short-term rows?

The NeuroSense Therapeutics Ltd. Ordinary Shares long-horizon scenario sits near $0.8822 with a modeled change of +27.86%. It compounds cycle-continuation assumptions over time, so it should be treated as a scenario envelope rather than a precise endpoint.

Q Where are NRSN support and resistance zones right now?

For NeuroSense Therapeutics Ltd. Ordinary Shares, nearest resistance is around $0.6693, while nearest support is around $0.7107. A clean break above resistance improves continuation odds, while repeated closes under support raise downside risk.

Q How fresh is the NeuroSense Therapeutics Ltd. Ordinary Shares market snapshot?

The displayed stock snapshot is labeled April 22 · 2026 at 07:03 UTC; the latest observed session range is roughly n/a to n/a. These checkpoints are rebuilt from the market feed so the FAQ, milestones, and support/resistance context stay tied to the same data refresh.